Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
flu vaccine
Biotech
FDA accepts filing for Moderna flu vaccine after swift rethink
The FDA has accepted Moderna’s revised influenza vaccine filing, putting the biotech on track to win approval before the 2026-27 flu season.
Nick Paul Taylor
Feb 18, 2026 9:21am
HHS stands behind FDA decision to spurn Moderna flu filing
Feb 11, 2026 3:13pm
Moderna hit with FDA refusal-to-file letter for mRNA flu shot
Feb 10, 2026 7:45pm
Sanofi abandons attempt to develop mRNA seasonal flu vaccine
Jan 29, 2026 10:26am
Pfizer details phase 3 data for mRNA flu vaccine
Nov 20, 2025 11:25am
Moderna flu vaccine beats approved competitor in fresh ph. 3 win
Jun 30, 2025 8:05am
